The Cost-Effectiveness of Tibial Metaphyseal Cones in Revision Total Knee Arthroplasty.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 35569918.
- Also identified by DOI 10.1016/j.arth.2021.12.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study is to evaluate the cost-effectiveness of tibial cones in revision total knee arthroplasty. A Markov model was used for cost-effectiveness analysis. The average cone price was obtained from Orthopedic Network News. The average cone aseptic loosening rate was determined by literature review. Hospitalization costs and baseline re-revision rates were calculated using the PearlDiver Database. The maximum cost-effective cone price varied from $3514 at age 40 to $648 at age 90, compared to the current average selling price of $4201. Cones became cost-effective with baseline aseptic loosening rates of 0.89% annually at age 40 to 4.38% annually at age 90, compared to the current average baseline loosening rate of 0.76% annually. For the average patient, tibial cones are not cost-effective, but may become so at lower prices, in younger patients, or in patients at substantially increased risk of aseptic loosening.
Medical subject headings
- Arthroplasty, Replacement, Knee
- Knee Prosthesis
Anatomy
- knee
- tibia